MedPage Today on MSN
Another IL-17A/F Blocker Moves Forward for Psoriatic Arthritis
Called sonelokimab, the product inhibits both the A and F isoforms of interleukin-17 (IL-17). In this mid-stage trial, well ...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth ...
Discover BioVie's latest clinical advancements in Parkinson's, long COVID, and ascites. Learn about investment potential and upcoming data readouts.
BioVie Inc. - Special CallCompany ParticipantsCuong Viet Do - President, CEO & DirectorConference Call ParticipantsCraig ...
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...
A single-step high-pressure industrial process replaces complex irradiation methods, producing quantum-grade nanodiamonds ...
Addiction science is increasingly looking beyond clinics to technologies we already wear on our wrists. A recent trial suggests that wearables, better known for counting steps or tracking sleep, may ...
Straight Arrow News on MSN
Cybersecurity researchers find vulnerabilities in popular tracking device
A popular device used to track personal belongings and ostensibly protect consumers from theft could expose significant ...
Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback